|
|||||
|
|
A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma |
|
| Authors: | Tejaswi V. Mudigonda Kenneth Wyman David R. Spigel Kimberly B. Dahlman F. Anthony Greco Igor Puzanov Mark C. Kelley John D. Hainsworth Jeffrey A. Sosman Douglas B. Johnson |
| Affiliation: | 1. Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA;2. Sarah Cannon Research Institute and Tennessee Oncology PLLC, Nashville, TN, USA;3. Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, USA;4. Division of Surgical Oncology, Vanderbilt University Medical Center, Nashville, TN, USA |
| Abstract: | |
| Keywords: | |